Letters Open access

Inhalation sedation in intensive care: an alternative but equally effective and safe method of sedation?

Authors

Published
6 November 2021
Section
Letters
Pages
56-59

Abstract

Not available.

Supporting Agencies

References

  1. Türktan M, Güleç E, Hatipoğlu Z, Ilgınel MT, Özcengiz D. The Effect of Sevoflurane and Dexmedetomidine on Pulmonary Mechanics in ICU Patients. Turk J Anaesthesiol Reanim. 2019 Jun; 47(3): 206–212
  2. Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC. Trattato di anestesia clinica - 7°Ed. Vol 1. Roma. Antonio Delfino Editore medicina-scienze; 2015
  3. Grabitz SD, Farhan HN, Ruscic KJ, Timm FP, Shin CH, Thevathasan T, Staehr-Rye AK, Kurth T, Eikermann M. Dose-Dependent Protective Effect of Inhalational Anesthetics Against Postoperative Respiratory Complications: A Prospective Analysis of Data on File From Three Hospitals in New England. Crit Care Med. 2017 Jan;45(1):e30-e39
  4. Manatpon P, Kofke WA. Toxicity of inhaled agents after prolonged administration. J Clin Monit Comput. 2018 Aug;32(4):651-666
  5. Jerath A, Parotto M, Wasowicz M, Ferguson ND. Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation? Am J Respir Crit Care Med. 2016 Jun 1;193(11):1202-12.
  6. Page V, Carraretto M. Volatile agents in critical care sedation: yes, no or maybe? Minerva Anestesiol. 2017 Jul;83(7):679-681
  7. Kim HY, Lee JE, Kim HY, Kim J. Volatile sedation in the intensive care unit: A systematic review and meta-analysis. Medicine (Baltimore). 2017 Dec;96(49):e8976
  8. Koutsogiannaki S, Shimaoka M, Yuki K. The Use of Volatile Anesthetics as Sedatives for Acute Respiratory Distress Syndrome. Transl Perioper Pain Med. 2019;6(2):27-38
  9. Manuale MIRUSTM Controller. Istruzioni d‘uso Software versione 1.05.04. Technologie Institut Medizin GmbH (TIM). Rev. M.00 of 2017 Apr
  10. Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018 Sep;46(9):e825-e873
  11. www.aslcn2.it/media/2013/07/Gas-anestetici.pdf
  12. Cabibel R, Gerard L, Maiter D, Collin V, Hantson P. Complete Nephrogenic Diabetes Insipidus After Prolonged Sevoflurane Sedation: A Case Report of 3 Cases. A A Pract. 2019 Mar 1;12(5):155-159
  13. Romagnoli S, Chelazzi C, Zagli G, Benvenuti F, Mancinelli P, Boninsegni P, Paparella L. Critical care sedation with sevoflurane: a single center experience with the new mirus system. Critical Care 2017, 21(Suppl 1):P274
  14. Herzog-Niescery J, Vogelsang H, Gude P, Seipp HM, Uhl W, Weber TP, Bellgardt M. Environmental safety: Air pollution while using MIRUSâ„¢ for short-term sedation in the ICU. Acta Anaesthesiol Scand. 2019 Jan;63(1):86-92.
  15. Molina Aragonés JM, Ayora Ayora A, Barbara Ribalta A, Gascó parici A, Medina Lavela JA, Sol Vidiella J, Sol López MH. Occupational exposure to volatile anaesthetics: a systematic review. Occup Med (Lond). 2016 Apr;66(3):202-7.

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.